SC
LLY icon

Swan Capital’s Eli Lilly LLY Stock Holding History

Swan Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
240
+90
+60% +$92K 0.1% 35
2026
Q1 		$138K Sell
150
-4
-3% -$4.05K 0.05% 46
2025
Q4 		$166K Sell
154
-1
-0.6% -$956 0.06% 43
2025
Q3 		$118K Buy
155
+2
+1% +$1.49K 0.05% 49
2025
Q2 		$119K Buy
153
+17
+13% +$13.2K 0.05% 45
2025
Q1 		$112K Hold
136
– – 0.05% 46
2024
Q4 		$105K Sell
136
-2
-1% -$1.66K 0.05% 47
2024
Q3 		$122K Buy
138
+2
+1% +$1.8K 0.06% 45
2024
Q2 		$123K Buy
+136
New +$109K 0.07% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swan Capital's LLY Position: Q2 2026 in Review

Swan Capital increased its Eli Lilly (LLY) stake by 60% in Q2 2026, buying an estimated $92K and bringing the position to 240 shares worth $288K. The position accounts for 0.1% of the portfolio, ranked #35.

Swan Capital first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Swan Capital held 240 shares of Eli Lilly worth $288K as of Q2 2026.
  • Swan Capital bought 90 Eli Lilly shares in Q2 2026, an estimated $92K.
  • Eli Lilly made up 0.1% of Swan Capital's portfolio in Q2 2026, its #35 holding.
  • Swan Capital first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.